These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2962092)

  • 41. Increased plasma 6-keto-PGF1 alpha in veno-occlusive disease of the liver following bone marrow transplantation.
    Chen YC; Wang CH; Lin DT; Lui LT; Yang PM; Kuo LL
    Bone Marrow Transplant; 1989 Mar; 4(2):211-2. PubMed ID: 2650794
    [No Abstract]   [Full Text] [Related]  

  • 42. Phase II trial of heparin prophylaxis for veno-occlusive disease of the liver in children undergoing bone marrow transplantation.
    Rosenthal J; Sender L; Secola R; Killen R; Millerick M; Murphy L; Cairo MS
    Bone Marrow Transplant; 1996 Jul; 18(1):185-91. PubMed ID: 8832013
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatic veno-occlusive disease following bone marrow transplantation.
    Grandt NC
    Oncol Nurs Forum; 1989; 16(6):813-7. PubMed ID: 2687804
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatic complications of bone marrow transplantation.
    Sale GE
    Prog Clin Biol Res; 1989; 309():349-56. PubMed ID: 2675103
    [No Abstract]   [Full Text] [Related]  

  • 45. Cyclophosphamide, cytosine arabinoside and TBI as a conditioning regimen for allogeneic bone marrow transplantation in patients with leukemia.
    Jillella AP; Doria R; Khan K; Zelterman D; Ahmad YH; Smith BR; Holmes W; Becker P; Roberts KB; Rappeport JM
    Bone Marrow Transplant; 1999 Jun; 23(11):1095-100. PubMed ID: 10382947
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A 32-year-old man with hepatitis C who developed progressive liver failure after a bone marrow transplant.
    Lyra AC; Brunt EM; Pincus S; Di Bisceglie AM
    Semin Liver Dis; 2002 Feb; 22(1):103-8. PubMed ID: 11928083
    [No Abstract]   [Full Text] [Related]  

  • 47. Successful treatment of severe hepatic veno-occlusive disease after allogeneic bone marrow transplantation by transjugular intrahepatic portosystemic stent-shunt (TIPS).
    Lévy V; Azoulay D; Rio B; Vincent F; Rabbat A; Hunault M; Bazarbachi A; Delmer A; Zittoun R
    Bone Marrow Transplant; 1996 Aug; 18(2):443-45. PubMed ID: 8864460
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bone marrow transplantation for leukocyte adhesion deficiency-I: case report.
    Al-wahadneh AM; Haddadin I; Hamouri M; Omari K; Aejellat F
    Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):564-7. PubMed ID: 17186693
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effects of pretreatment regimen on mice liver injury in hematopoietic stem cell transplantation].
    Jia L; Yan ZL; Xu SJ; Xu KL; Zeng LY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 41(5):803-6. PubMed ID: 21302445
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer.
    Anscher MS; Peters WP; Reisenbichler H; Petros WP; Jirtle RL
    N Engl J Med; 1993 Jun; 328(22):1592-8. PubMed ID: 8487801
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Research radiography in bone marrow transplantation.
    Westbrook C
    Radiography; 1984; 50(594):285-7. PubMed ID: 6390508
    [No Abstract]   [Full Text] [Related]  

  • 52. [Fulminant hepatitis-like veno-occlusive disease of the liver after allogeneic bone marrow transplantation in acute lymphoblastic leukemia].
    Naito H; Arioka H; Kobayashi R; Ishikawa Y
    Rinsho Ketsueki; 1993 May; 34(5):656-61. PubMed ID: 8315837
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation: possible beneficial use of low molecular weight heparin.
    Simon M; Hahn T; Ford LA; Anderson B; Swinnich D; Baer MR; Bambach B; Bernstein SH; Bernstein ZP; Czuczman MS; Slack JL; Wetzler M; Herzig G; Schriber J; McCarthy PL
    Bone Marrow Transplant; 2001 Mar; 27(6):627-33. PubMed ID: 11319593
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pilot trial of prophylactic ursodiol to decrease the incidence of veno-occlusive disease of the liver in allogeneic bone marrow transplant patients.
    Essell JH; Thompson JM; Harman GS; Halvorson RD; Snyder MJ; Callander NS; Clement DJ
    Bone Marrow Transplant; 1992 Oct; 10(4):367-72. PubMed ID: 1422493
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Whole-body irradiation for bone marrow transplantation].
    Di Pietrantonj F; Proietti A; Capirci C
    Radiol Med; 1984 Jun; 70(6):396-410. PubMed ID: 6398469
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Prophylaxis of hepatic veno-occlusive disease by low-molecular-weight heparin and lipo- prostaglandin E1 after allogeneic peripheral blood stem cell transplantation].
    Song CY; Li YH; Guo KY; Wu BY
    Di Yi Jun Yi Da Xue Xue Bao; 2003 May; 23(5):494, 497. PubMed ID: 12754143
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Veno-occlusive disease (VOD) of the liver in Korean patients following allogeneic bone marrow transplantation (BMT): efficacy of recombinant human tissue plasminogen activator (rt-PA) treatment.
    Lee JH; Lee KH; Choi JS; Zang DY; Kim SB; Kim SW; Suh C; Lee JS; Kim WK; Lee YS; Kim SH
    J Korean Med Sci; 1996 Apr; 11(2):118-26. PubMed ID: 8835758
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Functional hyperactivity of monocytes after bone marrow transplantation: possible relevance for the development of post-transplant complications or relapse.
    Castenskiold EC; Kelsey SM; Collins PW; Coldwell RD; Allen PD; Side LE; Makin HL; Goldstone AH; Newland AC
    Bone Marrow Transplant; 1995 Jun; 15(6):879-84. PubMed ID: 7581085
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Does high-dose intravenous immune globulin treatment after bone marrow transplantation increase mortality in veno-occlusive disease of the liver?
    Klaesson S; Ringdén O; Ljungman P; Aschan J; Hägglund H; Winiarski J
    Transplantation; 1995 Dec; 60(11):1225-30. PubMed ID: 8525515
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Hepatic veno-occlusive disease in a patient undergoing bone marrow autotransplant after busulfan and melphalan conditioning].
    Zuazu I; Brunet S; Fernández MT; Domingo-Albós A
    Med Clin (Barc); 1990 Jan; 94(3):119. PubMed ID: 2314142
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.